Stanford University, Stanford Cancer Center ( Site 0046) is a clinical research site located in Stanford, California, United States 94305.
Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Stanford University, Stanford Cancer Center ( Site 0046) has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Chronic Graft Versus Host Disease, Non-small Cell Lung Cancer, Chronic Lymphocytic Leukemia.
Sponsors: Pharmacyclics LLC., Merck Sharp & Dohme LLC.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Stanford
Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Stanford University, Stanford Cancer Center ( Site 0046) has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Stanford University, Stanford Cancer Center ( Site 0046) has 3 clinical trials on record, with 1 currently active. Their work covers Chronic Graft Versus Host Disease, Non-small Cell Lung Cancer, Chronic Lymphocytic Leukemia.
Stanford University, Stanford Cancer Center ( Site 0046) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.